APGE
Price
$36.85
Change
+$0.32 (+0.88%)
Updated
Apr 25 closing price
Capitalization
2.14B
22 days until earnings call
SYRE
Price
$14.13
Change
-$0.80 (-5.36%)
Updated
Apr 25 closing price
Capitalization
851.69M
11 days until earnings call
Ad is loading...

APGE vs SYRE

Header iconAPGE vs SYRE Comparison
Open Charts APGE vs SYREBanner chart's image
Apogee Therapeutics
Price$36.85
Change+$0.32 (+0.88%)
Volume$578.75K
Capitalization2.14B
Spyre Therapeutics
Price$14.13
Change-$0.80 (-5.36%)
Volume$387.94K
Capitalization851.69M
APGE vs SYRE Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. SYRE commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and SYRE is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (APGE: $36.53 vs. SYRE: $14.93)
Brand notoriety: APGE and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 0% vs. SYRE: 134%
Market capitalization -- APGE: $2.14B vs. SYRE: $851.69M
APGE [@Biotechnology] is valued at $2.14B. SYRE’s [@Biotechnology] market capitalization is $851.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 6 TA indicator(s) are bullish while SYRE’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 6 bullish, 4 bearish.
  • SYRE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both APGE and SYRE are a good buy in the short-term.

Price Growth

APGE (@Biotechnology) experienced а +10.33% price change this week, while SYRE (@Biotechnology) price change was +17.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -4.17%, and the average quarterly price growth was -12.27%.

Reported Earning Dates

APGE is expected to report earnings on May 19, 2025.

SYRE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.14B) has a higher market cap than SYRE($852M). APGE YTD gains are higher at: -19.360 vs. SYRE (-35.868). SYRE (-208.57M) and APGE (-216.68M) have comparable annual earnings (EBITDA) . SYRE has more cash in the bank: 603M vs. APGE (521M). SYRE has less debt than APGE: SYRE (0) vs APGE (11.8M). APGE (0) and SYRE (0) have equivalent revenues.
APGESYREAPGE / SYRE
Capitalization2.14B852M251%
EBITDA-216.68M-208.57M104%
Gain YTD-19.360-35.86854%
P/E RatioN/A1.68-
Revenue00-
Total Cash521M603M86%
Total Debt11.8M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGESYRE
RSI
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 6 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 6 days ago
90%
Momentum
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 6 days ago
85%
MACD
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
89%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
79%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
88%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA259.518.77
+3.50%
Tesla
SPY546.6911.27
+2.10%
SPDR® S&P 500® ETF
AAPL208.373.77
+1.84%
Apple
BTC.X93943.800000244.687500
+0.26%
Bitcoin cryptocurrency
GME27.08-0.04
-0.15%
GameStop Corp

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with ATXS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
N/A
ATXS - APGE
52%
Loosely correlated
+0.19%
SYRE - APGE
51%
Loosely correlated
+4.99%
ELVN - APGE
50%
Loosely correlated
+2.98%
CRNX - APGE
49%
Loosely correlated
+3.15%
KYMR - APGE
49%
Loosely correlated
+9.32%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+4.99%
BEAM - SYRE
53%
Loosely correlated
+1.51%
CGON - SYRE
52%
Loosely correlated
+3.81%
APGE - SYRE
51%
Loosely correlated
N/A
IMNM - SYRE
49%
Loosely correlated
+0.24%
ACLX - SYRE
49%
Loosely correlated
+0.53%
More